Somnics Showcases Newly Developed VITAL Ventilator forCOVID-19 Patients Debut at MEDICA 2021

Somnics, Inc. today announced that its consolidated revenue for June 2021 reached NT$11.736 million, benefiting from record sales of the...

Somnics Health announces the launch of iNAP Sleep, its innovative Obstructive Sleep Apnea (OSA) treatment and service coinciding with the...

Somnics, Inc. announced that the company has passed the GMP approval of the Korean Ministry of Food and Drug Safety (MFDS, formerly known...

Somnics, Inc. (6633) and Maxnerva Technology Services signed a cooperation agreement regarding the contract development and manufacturing...

Somnics, Inc. (6633) develops the patented negative air pressure Obstructive Sleep Apnea (OSA) therapy device and solution. It will...

Somnics iNAP One sleep therapy system will display in Taiwan excellence exhibition center.

Somnics iNAP One sleep therapy system will attend “2020 Taiwan Healthcare+ Expo.”

Somnics iNAP One sleep therapy system receive “2021 Taiwan Excellence Award”.

Somnics signs global sales contract with the JPL(Jet Propulsion Laboratory)of the NASA, which authorizes Somnics manufactures ventilators...